Treatment of attention deficit hyperactivity disorder in adults

References

• McCann BS, Roy-Byrne P. Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults. Compr. Psychiatry45(3), 175–183 (2004).
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Moulton JL III. Persistence of attention-deficit/hyperactivity disorder into adulthood: what have we learned from the prospective follow-up studies? J. Atten. Disord.7(2), 93–100 (2003).
   PubMedGoogle Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J. Abnorm. Psychol.111(2), 279–289 (2002).
   PubMed Web of Science ®Google Scholar
• Weiss G, Hechtman LT. Hyperactive Children Grown Up: ADHD in Children, Adolescents, and Adults. Second Edition. Guilford Press, NY, USA (1993).
   Google Scholar
• Wilens TE, Biederman J, Spencer TJ, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J. Clin. Psychopharmacol.15(4), 270–279 (1995).
   PubMed Web of Science ®Google Scholar
• Sachdev PS, Trollor JN. How high a dose of stimulant medication in adult attention deficit hyperactivity disorder? Aust. NZ J. Psychiatry34(4), 645–650 (2000).
   PubMed Web of Science ®Google Scholar
• Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am. J. Psychiatry142(5), 547–552 (1985).
   PubMed Web of Science ®Google Scholar
• Wender PH, Wolf LE, Wasserstein J. Adults with ADHD: an overview. Ann. NY Acad. Sci.931, 1–16 (2001).
   PubMed Web of Science ®Google Scholar
• Wender PH. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J. Clin. Psychiatry59(Suppl. 7), 76–79 (1998).
   PubMed Web of Science ®Google Scholar
• Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry52(6), 434–443 (1995).
   PubMed Web of Science ®Google Scholar
• Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F. The efficacy of two different dosages of methylphenidate in treating aduls with attention-deficit hyperactivity disorder. Can. J. Psychiatry48(8), 546–554 (2003).
   PubMed Web of Science ®Google Scholar
• Dorrego MF, Canevaro L, Kuzis G, Sabe L, Starkstein SE. A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J. Neuropsychiatry Clin. Neurosci.14(3), 289–295 (2002).
   PubMed Web of Science ®Google Scholar
• Stein M. Multisite community open label study of concerta in adolescents and adults with ADHD. 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry. Miami, FL, USA (2003).
   Google Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol.24(1), 24–29 (2004).
   PubMed Web of Science ®Google Scholar
• Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust. NZ J. Psychiatry33(4), 494–502 (1999).
   PubMed Web of Science ®Google Scholar
• Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J. Clin. Psychiatry61(6), 414–417 (2000).
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psych.58(8), 775–782 (2001).
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T, Chrisman AK, Wilens T, Tullach S, Neister R. Long-term safety and efficacy of mixed amphetamine salts extended-release for adult ADHD. Syllabus and scientific proceedings: in summary form. 157th annual Meeting of the American Psychiatric Association. NY, USA, 106, 114 (2004).
   Google Scholar
• Wender P. Attention-deficit hyperactivity disorder in adults. Psychiatr. Clin. North Am.21(4), 761–774 (1998).
   PubMed Web of Science ®Google Scholar
• Heiligenstein E, Anders J. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse. J. Am. Coll. Health45(5), 225–229 (1997).
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J. Clin. Psychiatry59(Suppl. 7), 59–68 (1998).
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol. Psychiatry53(2), 112–120 (2003).
   PubMed Web of Science ®Google Scholar
• Henderson TA, Hartman K. Aggression, mania, and hypomania induction associated with atomoxetine. Pediatrics114(3), 895–896 (2004).
   PubMed Web of Science ®Google Scholar
• Wender PH, Wood DR, Reimherr FW, Ward M. An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res.9(4), 329–336 (1983).
   PubMedGoogle Scholar
• Higgins ES. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. J. Fam. Pract.48(1), 15–20 (1999).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Prince J et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am. J. Psychiatry153(9), 1147–1153 (1996).
   PubMed Web of Science ®Google Scholar
• Popper CW. Antidepressants in the treatment of attention-deficit/hyperactivity disorder. J. Clin. Psychiatry58(Suppl. 14), 14–31 (1997).
   PubMedGoogle Scholar
• Popper CW. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr. Clin. North Am.9(3), 605–646 (2000).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Spencer TJ, Biederman J et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am. J. Psychiatry158(2), 282–288 (2001).
   PubMed Web of Science ®Google Scholar
• Hedges D, Reimherr FW, Rogers A, Strong R, Wender PH. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol. Bull.31(4), 779–783 (1995).
   PubMed Web of Science ®Google Scholar
• Adler LA, Resnick S, Kunz M, Devinsky O. Open-label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol. Bull.31(4), 785–788 (1995).
   PubMed Web of Science ®Google Scholar
• Findling RL, Schwartz MA, Flannery DJ, Manos MJ. Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial. J. Clin. Psychiatry57(5), 184–189 (1996).
   PubMed Web of Science ®Google Scholar
• Wilens T. Pharmacological treatment of adult ADHD. Syllabus and scientific proceedings: in summary form. 157th annual Meeting of the American Psychiatric Association. NY, USA, 38F, 48 (2004).
   Google Scholar
• Prior FH, Isbister GK, Dawson AH, Whyte IM. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine. Med. J. Aust.176(5), 240–241 (2002).
   PubMed Web of Science ®Google Scholar
• Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin re-uptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J. Child Adolesc. Psychopharmacol.6(3), 165–175 (1996).
   PubMed Web of Science ®Google Scholar
• Hornig-Rohan M, Amsterdam JD. Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry26(3), 585–589 (2002).
   PubMed Web of Science ®Google Scholar
• Hechtman LT et al. Treatment of adults with ADHD and varying degrees of anxiety and depression. 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry. Miami, FL, USA (2003).
   Google Scholar
• Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J. Child Adolesc. Psychopharmacol.10(4), 311–320 (2000).
   PubMed Web of Science ®Google Scholar
• Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol.21(2), 223–228 (2001).
   PubMed Web of Science ®Google Scholar
• Conners CK, Levin ED, Sparrow E et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol. Bull.32(1), 67–73 (1996).
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, Kleber HD. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatr. Serv.50(8), 1001–1003 (1999).
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend.52(1), 15–25 (1998).
   PubMed Web of Science ®Google Scholar
• Schubiner H, Saules KK, Arfken CL et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp. Clin. Psychopharmacol.10(3), 286–294 (2002).
   PubMed Web of Science ®Google Scholar
• Castaneda R, Levy R, Hardy M, Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatr. Serv.51(2), 169–171 (2000).
   PubMed Web of Science ®Google Scholar
• Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr. Clin. North Am.27(2), 283–301 (2004).
   PubMed Web of Science ®Google Scholar
• Ingram S, Hechtman L, Morgenstern G. Outcome issues in ADHD: adolescent and adult long-term outcome. Ment. Retard. Dev. Disabil. Res. Rev.5(3), 243–250 (1999).
   Google Scholar
• Ratey JJ, Greenberg MS, Bemporad JR, Lindem KJ. Unrecognized attention-deficit hyperactivity disorder in adults presenting for out-patient psychotherapy. J. Child Adolesc. Psychopharmacol.2(4), 267–275 (1992).
   PubMedGoogle Scholar
• Weiss M, Hechtman LT, Weiss G. ADHD in Adulthood: a Guide to Current Theory, Diagnosis, and Treatment. Johns Hopkins University Press, MD, USA (1999).
   Google Scholar
• McDermott SP. Cognitive therapy for adults with attention-deficit/hyperactivity disorder. In: Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Brown TE (Ed.). American Psychiatric Press, Washington DC, USA, 569–606 (2000).
   Google Scholar
• Wilens TE, McDermott SP, Biederman J, Abrantes A, Hahesy A, Spencer TJ. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J. Cogn. Psychother.13(3), 215–226 (1999).
   Google Scholar
• Safren S, Otto MO, Wilens T, Sprich S, Biederman J, Winethe C. Cognitive-behavioral therapy for residual ADHD in adults. Syllabus and scientific proceedings: in summary form. 157th annual Meeting of the American Psychiatric Association. NY, USA, 104, 113 (2004).
   Google Scholar
• Safren SA, Sprich S, Chulvick S, Otto MW. Psychosocial treatments for adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North. Am.27(2), 349–360 (2004).
   PubMed Web of Science ®Google Scholar
• Mandelbaum S, Hechtman L, Ochs E et al. Psychosocial treatment of adults with ADHD. 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco, CA, USA (2002).
   Google Scholar
• Wiggins D, Singh K, Getz HG, Hutchins DE. Effects of brief group intervention for adults with attention deficit/hyperactivity disorder. J. Ment. Health Couns.21(1), 82–92 (1999).
   Google Scholar
• Hesslinger B, Tebartz van Elst L, Nyberg E et al. Psychotherapy of attention deficit hyperactivity disorder in adults – a pilot study using a structured skills training program. Eur. Arch. Psychiatry Clin. Neurosci.252(4), 177–184 (2002).
   PubMed Web of Science ®Google Scholar
• Stevenson A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust. NZ J. Psychiatry36(5), 610–616 (2002).
   PubMed Web of Science ®Google Scholar